Here are the Form 4 insider transactions from DuPont de Nemours, Inc. (DD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DD filings page.
DuPont de Nemours, Inc. reported a routine insider share acquisition by a director. On 11/26/2025, the director acquired 982.5051 shares of DuPont common stock at a price of $39.44 per share, as shown in Table I of the filing. Following this transaction, the director beneficially owned 34,421.4286 shares, held directly. The filing notes that this amount includes shares acquired through a dividend reinvestment program, meaning dividends were automatically used to buy additional stock rather than being paid in cash.
DuPont de Nemours, Inc. director reports additional share ownership through dividend reinvestment. A company director filed a Form 4 disclosing the acquisition of 1,267.7484 shares of DuPont common stock on 11/26/2025 at a price of $39.44 per share. The transaction increased the director’s directly held stake to 75,473.223 shares.
The filing notes that the new shares were acquired pursuant to a dividend reinvestment, meaning cash dividends were automatically used to purchase additional DuPont stock rather than being paid out in cash. The form indicates the holdings are owned directly and does not list any derivative securities transactions.
DuPont de Nemours, Inc. director reported a small increase in ownership through automatic dividend reinvestment. On 11/26/2025, the director acquired 206.0091 shares of DuPont common stock at a price of $39.44 per share. After this transaction, the director beneficially owns 19,578.8854 shares in total, held directly. The filing notes that the reported amount includes shares acquired through a dividend reinvestment program.
DuPont de Nemours, Inc. insider equity transaction: The company’s SVP & General Counsel reported an option exercise and share sale in DuPont common stock. On 11/28/2025, the executive exercised stock options covering 6,005 shares at an exercise price of $28 per share, converting them into common stock. On the same date, 6,005 common shares were sold at a price of $39.79 per share.
Following these transactions, the reporting person directly beneficially owned 112,101.1276 shares of DuPont common stock. The options exercised were part of a grant originally dated 02/03/2019, with an expiration date of 02/02/2026, and the remaining balance of these options is now reported as zero.
DuPont de Nemours, Inc. reported an insider transaction by its CEO and director on 11/28/2025. The reporting person exercised 9,011 stock options with an exercise price of $28 per share, acquiring the same number of DuPont common shares. On the same date, the insider sold 9,011 shares of common stock in an open-market transaction coded as a sale.
The sale had a weighted average price of $39.4619, with trades ranging from $39.46 to $39.48. Following these transactions, the insider directly beneficially owned 288,325.6878 shares of DuPont common stock. The stock options involved were non-qualified options granted on 02/03/2019 with an expiration date of 02/02/2026, vesting in three substantially equal annual installments.